Skip to main content
Fig. 4 | EJNMMI Radiopharmacy and Chemistry

Fig. 4

From: GMP production of 6-[18F]Fluoro-l-DOPA for PET/CT imaging by different synthetic routes: a three center experience

Fig. 4

Clinical data from OUH. A The composition of the subjects undergoing PET/CT scans with [18F]1 from 2017 until 2020. B and C PET/CT scan of a 3.5-month-old girl suffering from congenital hyperinsulinism. (B) gives the maximum intensity projection while (C) gives the transverse plane image. The red arrows indicate the minuscule lesion with uptake of [18F]1 in the cauda of pancreas

Back to article page